Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17717 | 27639088 | Hepatology | Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. | 2016 | Details |
| A17718 | 27637587 | J Gastroenterol | Nonalcoholic fatty liver disease in Asia: emerging perspectives. | 2016 | Details |
| A17719 | 27636929 | Ter Arkh | [Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study]. | 2017 | Details |
| A17720 | 27636408 | J Clin Gastroenterol | Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. | 2017 | Details |
| A17721 | 27635173 | J Clin Med Res | Astaxanthin as a Potential Protector of Liver Function: A Review. | 2016 | Details |
| A17722 | 27635163 | J Ultrasound | Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. | 2016 | Details |
| A17723 | 27634970 | QJM | Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. | 2017 | Details |
| A17724 | 27634656 | Histopathology | Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. | 2016 | Details |
| A17725 | 27634642 | J Investig Med | Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey. | 2016 | Details |
| A17726 | 27634369 | Liver Int | Current challenges and future directions for liver transplantation. | 2016 | Details |
| A17727 | 27634010 | Am J Physiol Gastrointest Liver Physiol | Statins improve NASH via inhibition of RhoA and Ras. | 2016 | Details |
| A17729 | 27633274 | Sci Rep | Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. | 2016 | Details |
| A17730 | 27633111 | Adv Nutr | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms. | 2016 | Details |
| A17731 | 27632923 | Nutr Res | Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα. | 2016 | Details |
| A17732 | 27632911 | Nutr Res | Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet. | 2016 | Details |
| A17733 | 27632189 | PLoS Comput Biol | A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. | 2016 | Details |
| A17734 | 27631178 | Arch Iran Med | Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial. | 2016 | Details |
| A17735 | 27631137 | Diabetologia | The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice. | 2016 | Details |
| A17736 | 27629750 | J Transl Med | Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17737 | 27628945 | J Dig Dis | MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease. | 2016 | Details |
| A17738 | 27628583 | Endocrine | Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. | 2016 | Details |
| A17739 | 27628106 | Diabetologia | Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice. | 2016 | Details |
| A17740 | 27627981 | Diabetologia | Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial. | 2016 | Details |
| A17741 | 27627804 | PLoS One | Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17742 | 27626926 | Cell Physiol Biochem | Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells. | 2016 | Details |
| A17744 | 27625763 | Int J Prev Med | Intake of Nutrients, Fiber, and Sugar in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Individuals. | 2016 | Details |
| A17745 | 27624887 | Gut | Epigenetics in liver disease: from biology to therapeutics. | 2016 | Details |
| A17746 | 27624512 | Pediatrics | Lysosomal Acid Lipase Deficiency Unmasked in Two Children With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17747 | 27623186 | Dig Liver Dis | Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection. | 2016 | Details |
| A17748 | 27621595 | Drug Des Devel Ther | The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease. | 2016 | Details |
| A17749 | 27621581 | World J Gastroenterol | Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development. | 2016 | Details |
| A17750 | 27621571 | World J Gastroenterol | Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? | 2016 | Details |
| A17751 | 27621190 | Metabolism | Activin A and follistatin in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17752 | 27621009 | J Surg Res | The impact of postoperative adjuvant chemotherapy on the development of nonalcoholic fatty liver disease after pancreatoduodenectomy. | 2015 | Details |
| A17753 | 27620899 | Psychopharmacology (Berl) | Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study. | 2016 | Details |
| A17754 | 27619340 | Lipids Health Dis | Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value. | 2016 | Details |
| A17755 | 27618908 | Nutrients | Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI. | 2016 | Details |
| A17756 | 27617201 | Mol Metab | Non-alcoholic fatty liver and the gut microbiota. | 2016 | Details |
| A17757 | 27616896 | J Ginseng Res | Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A17758 | 27616599 | Sci Rep | Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. | 2016 | Details |
| A17759 | 27616339 | Scand J Gastroenterol | SAF score and mortality in NAFLD after up to 41 years of follow-up. | 2016 | Details |
| A17760 | 27615366 | Hepatol Res | Establishment of mouse Mac-2 binding protein enzyme-linked immunosorbent assay and its application for mouse chronic liver disease models. | 2016 | Details |
| A17762 | 27614103 | Liver Int | Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency. | 2016 | Details |
| A17763 | 27614004 | Clin Respir J | Effect of continuous positive airway pressure on liver enzymes in obstructive sleep apnea: A meta-analysis. | 2016 | Details |
| A17764 | 27613825 | Physiol Rep | Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice. | 2016 | Details |
| A17765 | 27613713 | Toxicol Sci | From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis. | 2016 | Details |
| A17766 | 27613163 | Mol Cell Biochem | Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver. | 2016 | Details |
| A17767 | 27612024 | Sci Rep | Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. | 2016 | Details |
| A17768 | 27610012 | World J Gastroenterol | Metabolic aspects of adult patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17769 | 27610009 | World J Gastroenterol | Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis? | 2016 | Details |
| A17770 | 27609847 | BMJ Open | Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study. | 2016 | Details |
| A17771 | 27609031 | Exp Mol Med | MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. | 2016 | Details |
| A17772 | 27606822 | J Magn Reson Imaging | Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI. | 2016 | Details |
| A17773 | 27605877 | World J Gastroenterol | Metabolic complications in liver transplant recipients. | 2016 | Details |
| A17775 | 27604194 | Thromb Haemost | ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis. | 2016 | Details |
| A17776 | 27604106 | Drug Metab Dispos | Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes. | 2016 | Details |
| A17777 | 27603810 | Minerva Gastroenterol Dietol | Glutathione in the treatment of liver diseases: insights from clinical practice. | 2016 | Details |
| A17779 | 27600823 | Am J Physiol Endocrinol Metab | Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis. | 2016 | Details |
| A17780 | 27600326 | J Hum Nutr Diet | Waist-to-height ratio is independently related to whole and central body fat, regardless of the waist circumference measurement protocol, in non-alcoholic fatty liver disease patients. | 2016 | Details |
| A17781 | 27599824 | J Hepatol | Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. | 2016 | Details |
| A17782 | 27599521 | Gut | Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. | 2016 | Details |
| A17783 | 27597641 | Clin Res Hepatol Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. | 2016 | Details |
| A17784 | 27596100 | BMC Med Genet | The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). | 2016 | Details |
| A17785 | 27594839 | Front Physiol | Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis. | 2016 | Details |
| A17786 | 27594563 | Postepy Hig Med Dosw (Online) | New peptides players in metabolic disorders. | 2016 | Details |
| A17788 | 27593525 | Diabetes Obes Metab | Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: A randomized crossover study. | 2016 | Details |
| A17789 | 27592832 | Yakugaku Zasshi | Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver. | 2016 | Details |
| A17790 | 27589792 | Nutrients | Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue. | 2016 | Details |
| A17791 | 27588170 | Biomed Rep | Interaction between periodontitis and liver diseases. | 2016 | Details |
| A17793 | 27586548 | Croat Med J | Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial. | 2016 | Details |
| A17794 | 27583084 | Pan Afr Med J | Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus. | 2016 | Details |
| A17795 | 27582882 | Therap Adv Gastroenterol | Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. | 2016 | Details |
| A17796 | 27582024 | Clin Appl Thromb Hemost | Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer. | 2016 | Details |
| A17797 | 27581063 | Clin Gastroenterol Hepatol | Nonobese Fatty Liver Disease. | 2016 | Details |
| A17798 | 27580542 | Intern Med | Usefulness of Magnetic Resonance Imaging for the Diagnosis of Hemochromatosis with Severe Hepatic Steatosis in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17799 | 27580477 | J Clin Gastroenterol | The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population. | 2017 | Details |
| A17800 | 27579785 | PLoS One | Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17801 | 27577861 | Hepatol Res | Genetic prevention of hepatitis C virus-induced liver fibrosis by allele-specific downregulation of MERTK. | 2016 | Details |
| A17802 | 27577854 | Am J Physiol Endocrinol Metab | Treatment of nonalcoholic fatty liver disease: role of AMPK. | 2016 | Details |
| A17803 | 27576208 | Surg Obes Relat Dis | PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. | 2016 | Details |
| A17806 | 27572914 | Sci Rep | Lack of association between SREBF-1c gene polymorphisms and risk of non-alcoholic fatty liver disease in a Chinese Han population. | 2016 | Details |
| A17807 | 27571466 | Recenti Prog Med | [Non-alcoholic fatty liver disease (NAFLD)]. | 2016 | Details |
| A17808 | 27571403 | J Magn Reson Imaging | In vivo triglyceride composition of abdominal adipose tissue measured by 1 H MRS at 3T. | 2016 | Details |
| A17809 | 27570425 | World J Gastroenterol | Herbal medicines and nonalcoholic fatty liver disease. | 2016 | Details |
| A17810 | 27569462 | Orv Hetil | [Influence of non-alcoholic fatty liver disease on geno- and immunotoxic alterations of peripheric blood lymphocytes of oil refinery workers]. | 2016 | Details |
| A17811 | 27567038 | Ultrasonics | Development of non-invasive method for assessment of hepatic steatosis. | 2016 | Details |
| A17812 | 27565159 | Eat Weight Disord | Beverage consumption and paediatric NAFLD. | 2016 | Details |
| A17813 | 27564680 | Ann Surg | Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy. | 2017 | Details |
| A17814 | 27564402 | Expert Opin Pharmacother | Emerging and future therapies for nonalcoholic steatohepatitis in adults. | 2016 | Details |
| A17815 | 27563875 | Int J Mol Sci | Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17816 | 27563632 | Adv Biomed Res | Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease. | 2016 | Details |
| A17817 | 27563019 | Gut Liver | Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions. | 2016 | Details |
| A17818 | 27562716 | Biochem Biophys Res Commun | Metabolic biomarkers for non-alcoholic fatty liver disease induced by high-fat diet: In vivo magnetic resonance spectroscopy of hyperpolarized [1-13C] pyruvate. | 2016 | Details |
| A17819 | 27562557 | Toxicol Sci | Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis. | 2016 | Details |
| A17820 | 27561907 | Exp Clin Transplant | Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report. | 2016 | Details |
| A17822 | 27560482 | PLoS One | Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials. | 2016 | Details |
| A17823 | 27556491 | Cancers (Basel) | Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis. | 2016 | Details |
| A17824 | 27554622 | Surgery | The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis. | 2016 | Details |
| A17825 | 27554471 | Diabetes | Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1. | 2016 | Details |
| A17826 | 27553225 | FASEB J | Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses. | 2016 | Details |